Form 8-K - Current report:
SEC Accession No. 0001558370-23-016977
Filing Date
2023-10-30
Accepted
2023-10-30 07:37:59
Documents
16
Period of Report
2023-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgtx-20231030x8k.htm   iXBRL 8-K 44982
2 EX-10.1 mgtx-20231030xex10d1.htm EX-10.1 279327
3 EX-10.2 mgtx-20231030xex10d2.htm EX-10.2 90838
4 EX-99.1 mgtx-20231030xex99d1.htm EX-99.1 20836
5 GRAPHIC mgtx-20231030xex99d1002.jpg GRAPHIC 3029
  Complete submission text file 0001558370-23-016977.txt   643912

Data Files

Seq Description Document Type Size
6 EX-101.SCH mgtx-20231030.xsd EX-101.SCH 3123
7 EX-101.LAB mgtx-20231030_lab.xml EX-101.LAB 16582
8 EX-101.PRE mgtx-20231030_pre.xml EX-101.PRE 10450
10 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20231030x8k_htm.xml XML 5096
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 231357218
SIC: 2836 Biological Products, (No Diagnostic Substances)